Recent advances in polymer-coated iron oxide nanoparticles as magnetic resonance imaging contrast agents
Source abstract
Abstract
The surface–chemically modified superparamagnetic iron oxide nanoparticles are broadly investigated as magnetic resonance imaging contrast agents based on their unique characteristics such as high magnetization values, diameter from 4 to 100 nm, and narrow distribution of particle size. However, naked nanoparticles might be easily oxidized by the air leading to loss of dispersibility and magnetization. Therefore, suitable surface coating strategies were developed to increase the stability of magnetic iron oxide contrast agents in the physiological conditions. In addition, the polymer-coated agents possess an improved biocompatibility in comparison with conventional agents. This review discusses important aspects of newly developed magnetic contrast agents such as chemical synthesis strategies, physical parameters, relaxivity parameters, the effect of various coatings, and emerging applications. Disadvantages associated with commercially available gadolinium contrast agents are considered, and the advantages of potential applications of iron oxide alternatives to traditional agents are presented. Finally, perspectives of the future developments, applications, and concerns of the magnetic nanoparticles are also included.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Abbate V, Hider R (2017) Iron in biology. Metallomics 9:1467–1469. https://doi.org/10.1039/C7MT90039B10.1039/C7MT90039B ↗
2. Akbar A, Riaz S, Ashraf R, Naseem S (2015) Magnetic and magnetization properties of iron oxide thin films by microwave assisted sol–gel route. J Sol-Gel Sci Technol 74:320–328. https://doi.org/10.1007/s10971-014-3528-910.1007/s10971-014-3528-9 ↗
3. Arimoto R, Balsam W, Schloesslin C (2002) Visible spectroscopy of aerosol particles collected on filters: iron-oxide minerals. Atmos Environ 36:89–96. https://doi.org/10.1016/S1352-2310(01)00465-410.1016/S1352-2310(01)00465-4 ↗
4. Arsalani N, Fattahi H, Laurent S, Burtea C, Elst LV, Muller RN (2012) Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. Contrast Media Mol Imaging 7:185–194. https://doi.org/10.1002/cmmi.47910.1002/cmmi.479 ↗
5. Bar-Shir A, Avram L, Yariv-Shoushan S, Anaby D, Cohen S, Segev-Amzaleg N, Frenkel D, Sadan O, Offen D, Cohen Y (2014) Alginate-coated magnetic nanoparticles for noninvasive MRI of extracellular calcium. NMR Biomed 27:774–783. https://doi.org/10.1002/nbm.311710.1002/nbm.3117 ↗
6. Basly B, Felder-Flesch D, Perriat P, Billotey C, Taleb J, Pourroy G, Begin-Colin S (2010) Dendronized iron oxide nanoparticles as contrast agents for MRI. Chem Commun 46:985–987. https://doi.org/10.1039/B920348F10.1039/B920348F ↗
7. Basly B, Popa G, Fleutot S, Pichon BP, Garofalo A, Ghobril C, Billotey C, Berniard A, Bonazza P, Martinez H, Felder-Flesch D, Begin-Colin S (2013) Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents. Dalton Trans 42:2146–2157. https://doi.org/10.1039/C2DT31788E10.1039/C2DT31788E ↗
8. Bautista MC, Bomati-Miguel O, Zhao X, Morales MP, Gonzalez-Carreno T, Pérez de Alejo R, Ruiz-Cabello J, Veintemillas-Verdaguer S (2004) Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging. Nanotechnology 15:154–159. https://doi.org/10.1088/0957-4484/15/4/00810.1088/0957-4484/15/4/008 ↗
9. Bautista MC, Bomati-Miguel O, del Puerto MM, Serna CJ, Veintemillas-Verdaguer S (2005) Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation. J Magn Magn Mater 293:20–27. https://doi.org/10.1016/j.jmmm.2005.01.03810.1016/j.jmmm.2005.01.038 ↗
10. Beg MS, Mohapatra J, Pradhan L, Patkar D, Bahadur D (2017) Porous Fe3O4-SiO2 core-shell nanorods as high-performance MRI contrast agent and drug delivery vehicle. J Magn Magn Mater 428:340–347. https://doi.org/10.1016/j.jmmm.2016.12.07910.1016/j.jmmm.2016.12.079 ↗
11. Behzadi AH, Zhao Y, Farooq Z, Prince MR (2017) Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology 286:471–482. https://doi.org/10.1148/radiol.201716274010.1148/radiol.2017162740 ↗
12. Berger F, Kubik-Huch RA, Niemann T, Schmid HR, Poetzsch M, Froehlich JM, Beer JH, Kraemer T (2018) Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans. Radiology 288:703–709. https://doi.org/10.1148/radiol.201817182910.1148/radiol.2018171829 ↗
13. Blahut J, Bernášek K, Gálisová A, Herynek V, Císařová I, Kotek J, Lang J, Matějková S, Hermann P (2017) Paramagnetic 19F relaxation enhancement in nickel (II) complexes of N-trifluoroethyl cyclam derivatives and cell labeling for 19F MRI. Inorg Chem 56:13337–11348. https://doi.org/10.1021/acs.inorgchem.7b0211910.1021/acs.inorgchem.7b02119 ↗
14. Blumfield E, Moore MM, Drake MK, Goodman TR, Lewis KN, Meyer LT, Ngo TD, Sammet C, Stanescu AL, Swenson DW, Slovis TL, Iyer RS (2017) Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report. Pediatr Radiol 47:665–673. https://doi.org/10.1007/s00247-017-3807-z10.1007/s00247-017-3807-z ↗
15. Bonnet CS, Fries PH, Crouzy S, Delangle P (2010) Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water. J Phys Chem 114:8770–8781. https://doi.org/10.1021/jp101443v10.1021/jp101443v ↗
16. Boyer C, Whittaker MR, Bulmus V, Liu J, Davis TP (2010) The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. NPG Asia Mater 2:23–30. https://doi.org/10.1038/asiamat.2010.610.1038/asiamat.2010.6 ↗
17. Bulte JW, de Jonge MW, Kamman RL, Go KG, Zuiderveen F, Blaauw B, Oosterbaan JA, Hauw T, de Leij L (1992) Dextran-magnetite particles: contrast-enhanced MRI of blood–brain barrier disruption in a rat model. Magn Reson Med 23:215–223. https://doi.org/10.1002/mrm.191023020310.1002/mrm.1910230203 ↗
18. Bulte JWM, Douglas T, Witwer B, Zhang S-C, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141–1147. https://doi.org/10.1038/nbt1201-114110.1038/nbt1201-1141 ↗
19. Cai H, Li K, Li J, Wen S, Chen Q, Shen M, Zheng L, Zhang G, Shi X (2015) Dendrimer-assisted formation of Fe3O4/Au nanocomposite particles for targeted dual mode CT/MR imaging of tumors. Small 11:4584–4593. https://doi.org/10.1002/smll.20150085610.1002/smll.201500856 ↗
20. Cao Y, Liu M, Zhang K, Zu G, Kuang Y, Tong X, Xiong D, Pei R (2016a) Poly (glycerol) used for constructing mixed polymeric micelles as T1 MRI contrast agent for tumor-targeted imaging. Biomacromolecules 18:150–158. https://doi.org/10.1021/acs.biomac.6b0143710.1021/acs.biomac.6b01437 ↗
21. Cao Y, Liu M, Zhang K, Dong J, Zu G, Chen Y, Zhang T, Xiong D, Pei R (2016b) Preparation of linear poly (glycerol) as a T 1 contrast agent for tumor-targeted magnetic resonance imaging. J Mater Chem 4:6716–6725. https://doi.org/10.1039/C6TB01514J10.1039/C6TB01514J ↗
22. Caravan P (2006) Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 35:512–523. https://doi.org/10.1039/B510982P10.1039/B510982P ↗
23. Chang Y, Liu N, Chen L, Meng X, Liu Y, Li Y, Wang J (2012a) Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J Mater Chem 22:9594–9601. https://doi.org/10.1039/C2JM16792A10.1039/C2JM16792A ↗
24. Chang Y, Liu N, Chen L, Meng X, Liu Y, Li Y, Wang J (2012b) Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J. Mater. Chem. 22:9594–9601. https://doi.org/10.1039/C2JM16792A10.1039/C2JM16792A ↗
25. Chen TJ, Cheng TH, Chen CY, Hsu SC, Cheng TL, Liu GC, Wang YM (2009) Targeted Herceptin–dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem 14:253–260. https://doi.org/10.1007/s00775-008-0445-910.1007/s00775-008-0445-9 ↗
26. Chen YJ, Tao J, Xiong F, Zhu JB, Gu N, Geng KK (2010) Characterization and in vitro cellular uptake of PEG coated iron oxide nanoparticles as MRI contrast agent. Pharmazie 65:481–486
27. Chen W, Lu F, Chen CCV, Mo KC, Hung Y, Guo ZX, Lin C-H, Lin M-H, Lin Y-H, Chang C, Mou C-Y (2013) Manganese-enhanced MRI of rat brain based on slow cerebral delivery of manganese (II) with silica-encapsulated MnxFe1–xO nanoparticles. NMR Biomed 26:1176–1185. https://doi.org/10.1002/nbm.293210.1002/nbm.2932 ↗
28. Cheng C, Xu F, Gu H (2011) Facile synthesis and morphology evolution of magnetic iron oxide nanoparticles in different polyol processes. New J Chem 35:1072–1079. https://doi.org/10.1039/C0NJ00986E10.1039/C0NJ00986E ↗
29. Cheng Z, Dai Y, Kang X, Li C, Huang S, Lian H, Hou Z, Ma P, Lin J (2014) Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI. Biomaterials 35:6359–6368. https://doi.org/10.1016/j.biomaterials.2014.04.02910.1016/j.biomaterials.2014.04.029 ↗
30. Cheng W, Xu X, Wu F, Li J (2016) Synthesis of cavity-containing iron oxide nanoparticles by hydrothermal treatment of colloidal dispersion. Mater Lett 164:210–212. https://doi.org/10.1016/j.matlet.2015.10.17010.1016/j.matlet.2015.10.170 ↗
31. Clauson RM, Chen M, Scheetz LM, Berg B, Chertok B (2018) Size-controlled iron oxide nanoplatforms with lipidoid-stabilized shells for efficient magnetic resonance imaging-trackable lymph node targeting and high-capacity biomolecule display. ACS Appl Mater Interfaces 8:20281–20295. https://doi.org/10.1021/acsami.8b0283010.1021/acsami.8b02830 ↗
32. Coe CL, Lubach GR, Kling P, Georgieff M, Rao R, Connor J (2015) Iron biology is key to understanding how inflammation, stress and obesity affect maternal and child health, Brain, Behavior, and. Immunity. 49:e34. https://doi.org/10.1016/j.bbi.2015.06.13210.1016/j.bbi.2015.06.132 ↗
33. Cui X, Antonietti M, Yu SH (2006) Structural effects of iron oxide nanoparticles and iron ions on the hydrothermal carbonization of starch and rice carbohydrates. Small 2:756–759. https://doi.org/10.1002/smll.20060004710.1002/smll.200600047 ↗
34. Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Knüchel R, Kiessling F, Lammers T (2019) Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Delivery Rev 138:302–325. https://doi.org/10.1016/j.addr.2019.01.00510.1016/j.addr.2019.01.005 ↗
35. Dai F, Du M, Liu Y, Liu G, Liu Q, Zhang X (2014a) Folic acid-conjugated glucose and dextran coated iron oxide nanoparticles as MRI contrast agents for diagnosis and treatment response of rheumatoid arthritis. J Mater Chem 2:2240–2247. https://doi.org/10.1039/C3TB21732A10.1039/C3TB21732A ↗
36. Dai L, Liu Y, Wang Z, Guo F, Shi D, Zhang B (2014b) One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement. Mater Sci Eng 41:161–167. https://doi.org/10.1016/j.msec.2014.04.04110.1016/j.msec.2014.04.041 ↗
37. Darbandi M, Laurent S, Busch M, Li Z-A, Yuan Y, Krüger M, Farle M, Winterer M, Elst LV, Muller RN, Wende H (2013) Blocked-micropores, surface functionalized, bio-compatible and silica-coated iron oxide nanocomposites as advanced MRI contrast agent. J Nanopart Res 15:1664–1669. https://doi.org/10.1007/s11051-013-1664-810.1007/s11051-013-1664-8 ↗
38. Dekkers IA, Roos R, van der Molen AJ (2018) Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency. Eur Radiol 28:1579–1584. https://doi.org/10.1007/s00330-017-5065-810.1007/s00330-017-5065-8 ↗
39. El-Boubbou K (2018) Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery. Nanomedicine 13:929–952. https://doi.org/10.2217/nnm-2017-032010.2217/nnm-2017-0320 ↗
40. Fakayode OJ, Songca SP, Oluwafemi OS (2018) Neutral red separation property of ultrasmall-gluconic acid capped superparamagnetic iron oxide nanoclusters coprecipitated with goethite and hematite. Sep Purif Technol 192:475–482. https://doi.org/10.1016/j.seppur.2017.09.05010.1016/j.seppur.2017.09.050 ↗
41. Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ (2017) Gadolinium-based contrast agents: a comprehensive risk assessment. J Magn Reson Imaging 46:338–353. https://doi.org/10.1002/jmri.2562510.1002/jmri.25625 ↗
42. Gao GH, Lee JW, Nguyen MK, Im GH, Yang J, Heo H, Jeon P, Park TG, Lee JH, Lee DS (2011) pH-responsive polymeric micelle based on PEG-poly (β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. J Controlled Release 155:11–17. https://doi.org/10.1016/j.jconrel.2010.09.01210.1016/j.jconrel.2010.09.012 ↗
43. Gash AE, Tillotson TM, Satcher JH, Poco JF, Hrubesh LW, Simpson RL (2001) Use of epoxides in the sol−gel synthesis of porous iron (III) oxide monoliths from Fe (III) salts. Chem Mater 13:999–1007. https://doi.org/10.1021/cm000761110.1021/cm0007611 ↗
44. Ge S, Shi X, Sun K, Li C, Uher C, Baker JR, Horr MMB, Orr BG (2009) Facile hydrothermal synthesis of iron oxide nanoparticles with tunable magnetic properties. J Phys Chem C 113:13593–13599. https://doi.org/10.1021/jp902953t10.1021/jp902953t ↗
45. Gómez-Vallejo V, Puigivila M, Plaza-García S, Szczupak B, Piñol R, Murillo JL, Sorribas V, Lou G, Veintemillas S, Ramos-Cabrer P, Llop J, Millán A (2018) PEG-copolymer-coated iron oxide nanoparticles that avoid the reticuloendothelial system and act as kidney MRI contrast agents. Nanoscale 10:14153–14164. https://doi.org/10.1039/C8NR03084G10.1039/C8NR03084G ↗
46. Grover VP, Tognarelli JM, Crossey MM, Cox IJ, Taylor-Robinson SD, McPhail MJ (2015) Magnetic resonance imaging: principles and techniques: lessons for clinicians. J Clin Exp Hepatol 5:246–255. https://doi.org/10.1016/j.jceh.2015.08.00110.1016/j.jceh.2015.08.001 ↗
47. Gyergyek S, Makovec D, Jagodič M, Drofenik M, Schenk K, Jordan O, Kovač J, Dražič G, Hofmann H (2017) Hydrothermal growth of iron oxide NPs with a uniform size distribution for magnetically induced hyperthermia: structural, colloidal and magnetic properties. J Alloys Compd 694:261–271. https://doi.org/10.1016/j.jallcom.2016.09.23810.1016/j.jallcom.2016.09.238 ↗
48. Hachani R, Lowdell M, Birchall M, Hervault A, Mertz D, Begin-Colin S, Thanh NTK (2016) Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 8:3278–3287. https://doi.org/10.1039/C5NR03867G10.1039/C5NR03867G ↗
49. Hajela S, Botta M, Giraudo S, Xu J, Raymond KN, Aime S (2000) A tris-hydroxymethyl-substituted derivative of Gd-TREN-Me-3, 2-HOPO: an MRI relaxation agent with improved efficiency. J Am Chem Soc 122:11228–11129. https://doi.org/10.1021/ja994315u10.1021/ja994315u ↗
50. Han Y, Qian Y, Zhou X, Hu H, Liu X, Zhou Z, Tang J, Shen Y (2016) Facile synthesis of zwitterionic polyglycerol dendrimers with a β-cyclodextrin core as MRI contrast agent carriers. Polym Chem 7:6354–6362. https://doi.org/10.1039/C6PY01404F10.1039/C6PY01404F ↗
51. Hao R, Xing R, Xu Z, Hou Y, Gao S, Sun S (2010) Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv Mater 22:2729–2742. https://doi.org/10.1002/adma.20100026010.1002/adma.201000260 ↗
52. Haw CY, Mohamed F, Chia CH, Radiman S, Zakaria S, Huang NM, Lim HN (2010) Hydrothermal synthesis of magnetite nanoparticles as MRI contrast agents. Ceram Int 36:1417–1422. https://doi.org/10.1016/j.ceramint.2010.02.00510.1016/j.ceramint.2010.02.005 ↗
53. Hedayati M, Abubaker-Sharif B, Khattab M, Razavi A, Mohammed I, Nejad A, Wabler M, Zhou H, Mihalic J, Gruettner C, de Weese T (2018) An optimised spectrophotometric assay for convenient and accurate quantitation of intracellular iron from iron oxide nanoparticles. Int J Hyperth 34:373–381. https://doi.org/10.1080/02656736.2017.135440310.1080/02656736.2017.1354403 ↗
54. Henkelman RM, Stanisz GJ, Graham SJ (2001) Magnetization transfer in MRI: a review. NMR Biomed 14:57–64. https://doi.org/10.1002/nbm.68310.1002/nbm.683 ↗
55. Hermann P, Kotek J, Kubíček V, Lukeš I (2008) Gadolinium (III) complexes as MRI contrast agents: ligand design and properties of the complexes. Dalton Trans 23:3027–3047. https://doi.org/10.1039/B719704G10.1039/B719704G ↗
56. Hillman AL, Schwartz JS (1985) The adoption and diffusion of CT and MRI in the United States: a comparative analysis. Med Care 1:1283–1294 https://www.jstor.org/stable/376505110.1097/00005650-198511000-00007 ↗
57. Hong RY, Feng B, Chen LL, Liu GH, Li HZ, Zheng Y, Wei DG (2008) Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles. Biochem Eng J 42:290–300. https://doi.org/10.1016/j.bej.2008.07.00910.1016/j.bej.2008.07.009 ↗
58. Hu F, Jia Q, Li Y, Gao M (2011) Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1-and T2-weighted magnetic resonance imaging. Nanotechnology 22:245604. https://doi.org/10.1088/0957-4484/22/24/24560410.1088/0957-4484/22/24/245604 ↗
59. Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X, Chen X (2010) Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 4:7151–7160. https://doi.org/10.1021/nn101643u10.1021/nn101643u ↗
60. Hurley KR, Ring HL, Etheridge M, Zhang J, Gao Z, Shao Q, Klein ND, Szlag VM, Chung C, Reineke TM, Garwood M, Bischof JC, Haynes C (2016) Predictable heating and positive MRI contrast from a mesoporous silica-coated iron oxide nanoparticle. Mol Pharmaceutics 13:2172–2183. https://doi.org/10.1021/acs.molpharmaceut.5b0086610.1021/acs.molpharmaceut.5b00866 ↗
61. Hussain NHI, Mustafa MK, Asman S (2018) Synthesis of PANI/iron (II, III) oxide hybrid nanocomposites using sol-gel method. J Sci Technol 10:1–4 https://doi.org/10.0.120.160/jst.2018.10.01.00110.30880/jst.2018.10.01.001 ↗
62. Iqbal MZ, Ma X, Chen T, Zhang LE, Ren W, Xiang L, Wu A (2015) Silica-coated super-paramagnetic iron oxide nanoparticles (SPIONPs): a new type contrast agent of T1 magnetic resonance imaging (MRI). J Mater Chem B 3:5172–5181. https://doi.org/10.1039/C5TB00300H10.1039/C5TB00300H ↗
63. Jang H, Lee C, Nam GE, Quan B, Choi HJ, Yoo JS, Piao Y (2016) In vivo magnetic resonance and fluorescence dual imaging of tumor sites by using dye-doped silica-coated iron oxide nanoparticles. J Nanopart Res 18:41–45. https://doi.org/10.1007/s11051-016-3353-x10.1007/s11051-016-3353-x ↗
64. Juang JH, Wang JJ, Shen CR, Kuo CH, Chien YW, Kuo HY, Chien Y-W, Kuo H-Y, Tsai Z-T, Yen T-C (2010) Magnetic resonance imaging of transplanted mouse islets labeled with chitosan-coated superparamagnetic iron oxide nanoparticles. Transplant Proc 42:2104–2108. https://doi.org/10.1016/j.transproceed.2010.05.10310.1016/j.transproceed.2010.05.103 ↗
65. Kandasamy G, Maity D (2015) Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. Int J Pharmaceutics 496:191–218. https://doi.org/10.1016/j.ijpharm.2015.10.05810.1016/j.ijpharm.2015.10.058 ↗
66. Kaur G, Dogra V, Kumar R, Kumar S, Singh K (2018) Fabrication of iron oxide nanocolloids using metallosurfactant-based microemulsions: antioxidant activity, cellular, and genotoxicity toward Vitis vinifera. J Biomol Struct Dyn 37:892–909. https://doi.org/10.1080/07391102.2018.144225110.1080/07391102.2018.1442251 ↗
67. Kielar F, Cassino C, Leone L, Tei L, Botta M (2018) Macrocyclic trinuclear gadolinium (iii) complexes: the influence of the linker flexibility on the relaxometric properties. New J Chem 42:7984–7992. https://doi.org/10.1039/C7NJ04696K10.1039/C7NJ04696K ↗
68. Kim DK, Zhang Y, Voit W, Rao KV, Muhammed M (2001) Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Magn Mater 225:30–36. https://doi.org/10.1016/S0304-8853(00)01224-510.1016/S0304-8853(00)01224-5 ↗
69. Kim EH, Ahn Y, Lee HS (2007) Biomedical applications of superparamagnetic iron oxide nanoparticles encapsulated within chitosan. J Alloys Compd 434:633–636. https://doi.org/10.1016/j.jallcom.2006.08.31110.1016/j.jallcom.2006.08.311 ↗
70. Kumagai M, Imai Y, Nakamura T, Yamasaki Y, Sekino M, Ueno S, Hanaoka K, Kikuchi K, Nagano T, Kaneko E, Shimokado K, Kataoka K (2007) Iron hydroxide nanoparticles coated with poly (ethylene glycol)-poly (aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf B 56:174–181. https://doi.org/10.1016/j.colsurfb.2006.12.01910.1016/j.colsurfb.2006.12.019 ↗
71. Lamanna G, Kueny-Stotz M, Mamlouk-Chaouachi H, Ghobril C, Basly B, Bertin A, Miladi I, Billotey C, Pourroy G, Begin-Colin S, Felder-Flesch D (2011) Dendronized iron oxide nanoparticles for multimodal imaging. Biomaterials 32:8562–8573. https://doi.org/10.1016/j.biomaterials.2011.07.02610.1016/j.biomaterials.2011.07.026 ↗
72. Lassoued A, Dkhil B, Gadri A, Ammar S (2017) Control of the shape and size of iron oxide (α-Fe2O3) nanoparticles synthesized through the chemical precipitation method. Results phys 7:3007–3015. https://doi.org/10.1016/j.rinp.2017.07.06610.1016/j.rinp.2017.07.066 ↗
73. Lassoued A, Lassoued MS, Dkhil B, Ammar S, Gadri A (2018) Synthesis, photoluminescence and magnetic properties of iron oxide (α-Fe2O3) nanoparticles through precipitation or hydrothermal methods. Phys E 101:212–219. https://doi.org/10.1016/j.physe.2018.04.00910.1016/j.physe.2018.04.009 ↗
74. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110. https://doi.org/10.1021/cr068445e10.1021/cr068445e ↗
75. Lee N, Hyeon T (2012) Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 41:2575–2589. https://doi.org/10.1039/C1CS15248C10.1039/C1CS15248C ↗
76. Lee H, Shao H, Huang Y, Kwak B (2005) Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan. IEEE Trans Magn 41:4102–4104. https://doi.org/10.1109/TMAG.2005.85533810.1109/TMAG.2005.855338 ↗
77. Lee HY, Lee SH, Xu C, Xie J, Lee JH, Wu B, Koh AL, Wang X, Sinclair R, Wang SX, Nishimura DG, Biswal S, Sun S, Cho SH, Chen X (2008) Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology 19:165101. https://doi.org/10.1088/0957-4484/19/16/16510110.1088/0957-4484/19/16/165101 ↗
78. Li J, Shi X, Shen M (2014) Hydrothermal synthesis and functionalization of iron oxide nanoparticles for MR imaging applications. Part Part Syst Charact 31:1223–1237. https://doi.org/10.1002/ppsc.20140008710.1002/ppsc.201400087 ↗
79. Li D, Li SJ, Zhang Y, Jiang JJ, Gong WJ, Wang JH, Zhang ZD (2015) Monodisperse water-soluble-Fe2O3/polyvinylpyrrolidone nanoparticles for a magnetic resonance imaging contrast agent. Mater Res Innov 19:58–62. https://doi.org/10.1179/1432891715Z.000000000142810.1179/1432891715Z.0000000001428 ↗
80. Liao Z, Wang H, Lv R, Zhao P, Sun X, Wang S, Su W, Niu R, Chang J (2011) Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells. Langmuir 27:3100–3105. https://doi.org/10.1021/la105015710.1021/la1050157 ↗
81. Lin S, Lin K, Lu D, Liu Z (2017) Preparation of uniform magnetic iron oxide nanoparticles by co-precipitation in a helical module microchannel reactor. J Environ Chem Eng 5:303–309. https://doi.org/10.1016/j.jece.2016.12.01110.1016/j.jece.2016.12.011 ↗
82. Liu G, Sobering G, Duyn J, Moonen CT (1993) A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO). Magn Reson Med 30:764–768. https://doi.org/10.1002/mrm.191030061710.1002/mrm.1910300617 ↗
83. Liu DF, Qian C, An YL, Chang D, Ju SH, Teng GJ (2014) Magnetic resonance imaging of post-ischemic blood–brain barrier damage with PEGylated iron oxide nanoparticles. Nanoscale 6:15161–15167. https://doi.org/10.1039/C4NR03942D10.1039/C4NR03942D ↗
84. Liu J, Xu J, Zhou J, Zhang Y, Guo D, Wang Z (2017) Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis. Int J Nanomed 12:1113–1126. https://doi.org/10.2147/IJN.S12322810.2147/IJN.S123228 ↗
85. Lohrke J, Frenzel T, Endrikat J, Alves FC, Grist TM, Law M, Lee JM, Leiner T, Li K-C, Nikolaou K, Prince MR, Schild HH, Weinreb JC, Yoshikawa K, Pietsch H (2016) 25 years of contrast-enhanced MRI: developments, current challenges and future perspectives. Adv Ther 33:1–28. https://doi.org/10.1007/s12325-015-0275-410.1007/s12325-015-0275-4 ↗
86. López-Ramón MV, Álvarez MA, Moreno-Castilla C, Fontecha-Cámara MA, Yebra-Rodríguez Á, Bailón-García E (2018) Effect of calcination temperature of a copper ferrite synthesized by a sol-gel method on its structural characteristics and performance as Fenton catalyst to remove gallic acid from water. J Colloid Interface Sci 511:193–202. https://doi.org/10.1016/j.jcis.2017.09.11710.1016/j.jcis.2017.09.117 ↗
87. Lu Y, Yin Y, Mayers BT, Xia Y (2002) Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol−gel approach. Nano Lett 2:183–186. https://doi.org/10.1021/nl015681q10.1021/nl015681q ↗
88. Lunvongsa S, Oshima M, Motomizu S (2006) Determination of total and dissolved amount of iron in water samples using catalytic spectrophotometric flow injection analysis. Talanta 68:969–973. https://doi.org/10.1016/j.talanta.2005.06.06710.1016/j.talanta.2005.06.067 ↗
89. Luong D, Sau S, Kesharwani P, Iyer AK (2017) Polyvalent folate-dendrimer-coated iron oxide theranostic nanoparticles for simultaneous magnetic resonance imaging and precise cancer cell targeting. Biomacromolecules 18:1197–1209. https://doi.org/10.1021/acs.biomac.6b0188510.1021/acs.biomac.6b01885 ↗
90. Lutz JF, Stiller S, Hoth A, Kaufner L, Pison U, Cartier R (2006) One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules 7:3132–3138. https://doi.org/10.1021/bm060752710.1021/bm0607527 ↗
91. Ma HL, Qi XR, Maitani Y, Nagai T (2007) Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm 333:177–186. https://doi.org/10.1021/bm060752710.1021/bm0607527 ↗
92. Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T (2008) Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm 354:217–226. https://doi.org/10.1016/j.ijpharm.2007.11.03610.1016/j.ijpharm.2007.11.036 ↗
93. Maghsodi A, Adlnasab L, Shabanian M, Javanbakht M (2018) Optimization of effective parameters in the synthesis of nanopore anodic aluminum oxide membrane and arsenic removal by prepared magnetic iron oxide nanoparicles in anodic aluminum oxide membrane via ultrasonic-hydrothermal method. Ultrason Sonochem 48:441–452. https://doi.org/10.1016/j.ultsonch.2018.07.00310.1016/j.ultsonch.2018.07.003 ↗
94. Mahmed N, Heczko O, Lancok A, Hannula SP (2014) The magnetic and oxidation behavior of bare and silica-coated iron oxide nanoparticles synthesized by reverse co-precipitation of ferrous ion (Fe2+) in ambient atmosphere. J Magn Magn Mater 353:15–22. https://doi.org/10.1016/j.jmmm.2013.10.01210.1016/j.jmmm.2013.10.012 ↗
95. Mallakpour S, Madani M (2015) A review of current coupling agents for modification of metal oxide nanoparticles. Prog Org Coat 86:194–207. https://doi.org/10.1016/j.porgcoat.2015.05.02310.1016/j.porgcoat.2015.05.023 ↗
96. Mansfield P, Glover P, Bowtell R (1994) Active acoustic screening: design principles for quiet gradient coils in MRI. Meas Sci Technol 5:1021. https://doi.org/10.1088/0957-0233/5/8/02610.1088/0957-0233/5/8/026 ↗
97. Masoudi A, Hosseini HRM, Shokrgozar MA, Ahmadi R, Oghabian MA (2012) The effect of poly (ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent. Int J Pharm 433:129–141. https://doi.org/10.1016/j.ijpharm.2012.04.08010.1016/j.ijpharm.2012.04.080 ↗
98. Mogharabi-Manzari M, Amini M, Abdollahi M, Khoobi M, Bagherzadeh G, Faramarzi MA (2018a) Co-immobilization of Laccase and TEMPO in the Compartments of Mesoporous Silica for a Green and One-Pot Cascade Synthesis of Coumarins by Knoevenagel Condensation. ChemCatChem 10:1542–1546. https://doi.org/10.1002/cctc.20170152710.1002/cctc.201701527 ↗
99. Mogharabi-Manzari M, Kiani M, Aryanejad S, Imanparast S, Amini M, Faramarzi MA (2018b) A magnetic heterogeneous biocatalyst composed of immobilized laccase and 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) for green one-pot cascade synthesis of 2-substituted benzimidazole and benzoxazole derivatives under mild reaction conditions. Adv Syn Catal 360:3563–3571. https://doi.org/10.1002/adsc.20180045910.1002/adsc.201800459 ↗
100. Mogharabi-Manzari M, Ghahremani MH, Sedaghat T, Shayan F, Faramarzi MA (2019a) A laccase heterogeneous magnetic fibrous silica-based biocatalyst for green and one-pot cascade synthesis of chromene derivatives. Eur J Org Chem 2019:1741–1747. https://doi.org/10.1002/ejoc.20180178410.1002/ejoc.201801784 ↗